Trevi Therapeutics, Inc. TRVI Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period at other companies
Other financials
Where this comes from
Reported directly by Trevi Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod.
The official record: Trevi Therapeutics, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Trevi Therapeutics, Inc.'s share-based compensation arrangement by share-based payment award, options, forfeitures in period.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Trevi Therapeutics, Inc.'s share-based compensation arrangement by share-based payment award, options, forfeitures in period?
- Trevi Therapeutics, Inc. (TRVI) reported share-based compensation arrangement by share-based payment award, options, forfeitures in period of 331.2K in Q1 2026.
- How has Trevi Therapeutics, Inc.'s share-based compensation arrangement by share-based payment award, options, forfeitures in period changed year-over-year?
- Trevi Therapeutics, Inc.'s share-based compensation arrangement by share-based payment award, options, forfeitures in period increased by 394.3% year-over-year, from 67K to 331.2K.
- What does share-based compensation arrangement by share-based payment award, options, forfeitures in period mean?
- The total number of stock options granted to employees or directors that were forfeited during the reporting period due to failure to meet vesting conditions. This provides insight into employee retention and the turnover of equity-based incentive awards.